Glipizide 2 — Class II drug recall D-0482-2017
Terminated recall by RemedyRepack Inc., reported 2017-03-01, distributed in FL. Failed Dissolution Specifications
| Recall number | D-0482-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RemedyRepack Inc., Indiana, PA, United States |
| Recall initiated | 2017-02-07 |
| Classified | 2017-02-18 |
| Reported by FDA | 2017-03-01 |
| Terminated | 2017-05-05 |
| Distributed | FL |
| Reason classes | specification failure |
| NDC | 00591-0900-30, 52125-0764-02 |
| Lot numbers | 00591-0900-30, 10/17, B0129373-021916 |
Product
Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0482-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.